vs

Side-by-side financial comparison of Douglas Emmett Inc (DEI) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Douglas Emmett Inc is the larger business by last-quarter revenue ($249.4M vs $127.1M, roughly 2.0× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 1.8%). Douglas Emmett Inc produced more free cash flow last quarter ($194.5M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 0.9%).

Douglas Emmett Inc is a leading real estate investment trust (REIT) that owns, operates, and acquires high-quality office and multifamily residential properties. Its core operation areas are high-barrier-to-entry markets including Los Angeles in California and Honolulu in Hawaii, serving premium commercial and residential tenant segments.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

DEI vs ZLAB — Head-to-Head

Bigger by revenue
DEI
DEI
2.0× larger
DEI
$249.4M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+15.3% gap
ZLAB
17.1%
1.8%
DEI
More free cash flow
DEI
DEI
$221.2M more FCF
DEI
$194.5M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
0.9%
DEI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DEI
DEI
ZLAB
ZLAB
Revenue
$249.4M
$127.1M
Net Profit
$-6.8M
Gross Margin
62.2%
51.0%
Operating Margin
-54.6%
Net Margin
-2.7%
Revenue YoY
1.8%
17.1%
Net Profit YoY
-670.7%
EPS (diluted)
$-0.04
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DEI
DEI
ZLAB
ZLAB
Q4 25
$249.4M
$127.1M
Q3 25
$250.6M
$115.4M
Q2 25
$252.4M
$109.1M
Q1 25
$251.5M
$105.7M
Q4 24
$245.0M
$108.5M
Q3 24
$250.8M
$101.8M
Q2 24
$245.8M
$100.1M
Q1 24
$245.0M
$87.1M
Net Profit
DEI
DEI
ZLAB
ZLAB
Q4 25
$-6.8M
Q3 25
$-10.9M
$-36.0M
Q2 25
$-5.8M
$-40.7M
Q1 25
$39.8M
$-48.4M
Q4 24
$-888.0K
Q3 24
$4.6M
$-41.7M
Q2 24
$10.9M
$-80.3M
Q1 24
$8.9M
$-53.5M
Gross Margin
DEI
DEI
ZLAB
ZLAB
Q4 25
62.2%
51.0%
Q3 25
63.6%
59.5%
Q2 25
63.2%
60.6%
Q1 25
64.4%
63.6%
Q4 24
63.5%
61.5%
Q3 24
62.2%
64.1%
Q2 24
66.2%
64.9%
Q1 24
66.1%
61.4%
Operating Margin
DEI
DEI
ZLAB
ZLAB
Q4 25
-54.6%
Q3 25
-42.3%
Q2 25
-50.3%
Q1 25
-53.3%
Q4 24
-62.6%
Q3 24
-66.6%
Q2 24
-76.0%
Q1 24
-80.7%
Net Margin
DEI
DEI
ZLAB
ZLAB
Q4 25
-2.7%
Q3 25
-4.3%
-31.2%
Q2 25
-2.3%
-37.3%
Q1 25
15.8%
-45.8%
Q4 24
-0.4%
Q3 24
1.8%
-40.9%
Q2 24
4.4%
-80.2%
Q1 24
3.6%
-61.4%
EPS (diluted)
DEI
DEI
ZLAB
ZLAB
Q4 25
$-0.04
$-0.05
Q3 25
$-0.07
$-0.03
Q2 25
$-0.04
$-0.04
Q1 25
$0.24
$-0.04
Q4 24
$-0.01
$-0.09
Q3 24
$0.03
$-0.04
Q2 24
$0.06
$-0.08
Q1 24
$0.05
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DEI
DEI
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$340.8M
$689.6M
Total DebtLower is stronger
$5.5B
Stockholders' EquityBook value
$1.9B
$715.5M
Total Assets
$9.3B
$1.2B
Debt / EquityLower = less leverage
2.91×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DEI
DEI
ZLAB
ZLAB
Q4 25
$340.8M
$689.6M
Q3 25
$408.5M
$717.2M
Q2 25
$426.9M
$732.2M
Q1 25
$525.7M
$757.3M
Q4 24
$444.6M
$779.7M
Q3 24
$544.2M
$616.1M
Q2 24
$561.1M
$630.0M
Q1 24
$556.7M
$650.8M
Total Debt
DEI
DEI
ZLAB
ZLAB
Q4 25
$5.5B
Q3 25
$5.6B
Q2 25
$5.6B
Q1 25
$5.6B
Q4 24
$5.5B
Q3 24
$5.5B
Q2 24
$5.5B
Q1 24
$5.5B
Stockholders' Equity
DEI
DEI
ZLAB
ZLAB
Q4 25
$1.9B
$715.5M
Q3 25
$1.9B
$759.9M
Q2 25
$2.0B
$791.7M
Q1 25
$2.0B
$810.8M
Q4 24
$2.1B
$840.9M
Q3 24
$2.1B
$667.7M
Q2 24
$2.2B
$704.2M
Q1 24
$2.2B
$762.2M
Total Assets
DEI
DEI
ZLAB
ZLAB
Q4 25
$9.3B
$1.2B
Q3 25
$9.4B
$1.2B
Q2 25
$9.4B
$1.2B
Q1 25
$9.6B
$1.2B
Q4 24
$9.4B
$1.2B
Q3 24
$9.5B
$985.3M
Q2 24
$9.6B
$987.4M
Q1 24
$9.6B
$988.4M
Debt / Equity
DEI
DEI
ZLAB
ZLAB
Q4 25
2.91×
Q3 25
2.85×
Q2 25
2.78×
Q1 25
2.75×
Q4 24
2.67×
Q3 24
2.64×
Q2 24
2.56×
Q1 24
2.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DEI
DEI
ZLAB
ZLAB
Operating Cash FlowLast quarter
$386.9M
$-26.0M
Free Cash FlowOCF − Capex
$194.5M
$-26.7M
FCF MarginFCF / Revenue
78.0%
-21.0%
Capex IntensityCapex / Revenue
77.1%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$376.9M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DEI
DEI
ZLAB
ZLAB
Q4 25
$386.9M
$-26.0M
Q3 25
$109.8M
$-32.0M
Q2 25
$81.3M
$-31.0M
Q1 25
$132.6M
$-61.7M
Q4 24
$408.7M
$-55.8M
Q3 24
$103.7M
$-26.8M
Q2 24
$91.9M
$-42.2M
Q1 24
$139.0M
$-90.1M
Free Cash Flow
DEI
DEI
ZLAB
ZLAB
Q4 25
$194.5M
$-26.7M
Q3 25
$61.9M
$-35.0M
Q2 25
$30.2M
$-33.9M
Q1 25
$90.3M
$-63.2M
Q4 24
$241.4M
$-58.4M
Q3 24
$63.2M
$-28.2M
Q2 24
$52.2M
$-42.9M
Q1 24
$90.9M
$-91.1M
FCF Margin
DEI
DEI
ZLAB
ZLAB
Q4 25
78.0%
-21.0%
Q3 25
24.7%
-30.4%
Q2 25
11.9%
-31.1%
Q1 25
35.9%
-59.9%
Q4 24
98.5%
-53.8%
Q3 24
25.2%
-27.7%
Q2 24
21.2%
-42.9%
Q1 24
37.1%
-104.5%
Capex Intensity
DEI
DEI
ZLAB
ZLAB
Q4 25
77.1%
0.5%
Q3 25
19.1%
2.6%
Q2 25
20.3%
2.6%
Q1 25
16.8%
1.5%
Q4 24
68.3%
2.4%
Q3 24
16.1%
1.3%
Q2 24
16.1%
0.7%
Q1 24
19.6%
1.1%
Cash Conversion
DEI
DEI
ZLAB
ZLAB
Q4 25
Q3 25
Q2 25
Q1 25
3.33×
Q4 24
Q3 24
22.46×
Q2 24
8.44×
Q1 24
15.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DEI
DEI

Rental Revenue And Tenant Recovery Revenue$169.4M68%
Multifamily Segment$49.9M20%
Parking Revenue And Other Income$30.2M12%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons